4 completed, 2 terminated. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Terminated 2 |
Follow AST-120: new trials by email Literature Review of AST-120 trials Research Report on AST-120
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AST-120 Used to Treat Mild Hepatic Encephalopathy AST-120 - Mild Hepatic Encephalopathy | Phase 2 | Completed | Ocera Therapeutics | 148 | 2009-03-01 | 2014-06-18 |
| Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI AST-120, Celphere CP-305 - Gastroesophageal Reflux Disease (GERD) | Phase 2 | Terminated | Ocera Therapeutics | 4 | 2007-10-01 | 2014-06-18 |
| Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy AST-120, lactulose - Hepatic Encephalopathy | Phase 2 | Completed | Ocera Therapeutics | 40 | 2007-09-01 | 2014-05-30 |
| Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome AST-120, Celphere® CP-305 - Irritable Bowel Syndrome | Phase 2 | Completed | Ocera Therapeutics | 117 | 2007-08-01 | 2014-06-18 |
| Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis AST-120 - Pouchitis | Phase 2 | Terminated | Ocera Therapeutics | 2 | 2007-03-01 | 2014-06-18 |
| Safety and Efficacy of AST-120 in the Treatment of Pouchitis AST-120 - Pouchitis | Phase 2 | Completed | Ocera Therapeutics | 19 | 2007-02-01 | 2014-06-18 |
Hepatic Encephalopathy (2) · Liver Diseases (2) · Pouchitis (2) · Brain Diseases (1) · Cognitive Dysfunction (1) · Colitis, Ulcerative (1) · Fibrosis (1) · Gastroesophageal Reflux (1) · Irritable Bowel Syndrome (1) · Liver Failure (1)
United States (6) · Belgium (1)
Bo Shen, MD (1) · Darrell S. Pardi, MD (1) · Jan Tack, MD (1) · Jeff Bornstein, MD (1) · Paul Pockros, MD (1) · Ronnie Fass, MD (1)